Pro Nephro AKI (NGAL) is now FDA-Cleared     READ MORE

Key Investor Information

BioPorto is listed on the NASDAQ Copenhagen stock exchange.

ANNOUNCEMENTS

View BioPorto newswire announcements.

PRESENTATIONS

Recent investor presentations.

ANNUAL REPORTS

View BioPorto Annual Reports.

FINANCIALS

Annual key figures.

IR CALENDAR

Key dates on the financial calendar.

GENERAL MEETINGS

Details about the Annual General Meeting (AGM) and Extraordinary General Meeting (EGM).

SHARE OFFERINGS

Details of current & past offerings.

ANALYST COVERAGE

Contacts and reports.

Investor contacts

EU Investor Relations

Claus Thestrup, HC Andersen Capital

US Investor Relations

Ashley Robinson, LifeSci Advisors